Selected research
Industry Growth & Trends
Global AI-based Diabetic Eye Disease Screening System Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global AI-based Diabetic Eye Disease Screening System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for AI-based Diabetic Eye Disease Screening System is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for AI-based Diabetic Eye Disease Screening System is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI-based Diabetic Eye Disease Screening System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the AI-based Diabetic Eye Disease Screening System market include Remidio, Retmarker, VoxelCloud, Airdoc, Zhiyuan Huitu, IDx, LLC, Zhenhealth, Eyenuk and AEYE Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global AI-based Diabetic Eye Disease Screening System market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The AI-based Diabetic Eye Disease Screening System market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI-based Diabetic Eye Disease Screening System market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI-based Diabetic Eye Disease Screening System.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global AI-based Diabetic Eye Disease Screening System market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
AI-based Diabetic Eye Disease Screening System Market by Company
Remidio
Retmarker
VoxelCloud
Airdoc
Zhiyuan Huitu
IDx, LLC
Zhenhealth
Eyenuk
AEYE Health
Optomed
AI-based Diabetic Eye Disease Screening System Segment by Type
On-premise
Cloud-based
Hybrid Mode
AI-based Diabetic Eye Disease Screening System Segment by Application
General Hospitals
Ophthalmology Hospitals
Diabetes Specialty Hospitals
AI-based Diabetic Eye Disease Screening System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-based Diabetic Eye Disease Screening System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI-based Diabetic Eye Disease Screening System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-based Diabetic Eye Disease Screening System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of AI-based Diabetic Eye Disease Screening System companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- On-premise
- Cloud-based
- Hybrid Mode
Applications
- General Hospitals
- Ophthalmology Hospitals
- Diabetes Specialty Hospitals
Companies covered
- Remidio
- Retmarker
- VoxelCloud
- Airdoc
- Zhiyuan Huitu
- IDx, LLC
- Zhenhealth
- Eyenuk
- AEYE Health
- Optomed
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global AI-based Diabetic Eye Disease Screening System Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global AI-based Diabetic Eye Disease Screening System Market Size by Region (2021-2032)
- 1.4.1 Global AI-based Diabetic Eye Disease Screening System Market Size by Region (2021-2026)
- 1.4.2 Global AI-based Diabetic Eye Disease Screening System Market Size by Region (2027-2032)
- 1.5 Key Regions AI-based Diabetic Eye Disease Screening System Market Size (2021-2032)
- 1.5.1 North America AI-based Diabetic Eye Disease Screening System Market Size Growth Rate (2021-2032)
- 1.5.2 Europe AI-based Diabetic Eye Disease Screening System Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific AI-based Diabetic Eye Disease Screening System Market Size Growth Rate (2021-2032)
- 1.5.4 South America AI-based Diabetic Eye Disease Screening System Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size Growth Rate (2021-2032)
2 AI-based Diabetic Eye Disease Screening System Market by Type
- 2.1 Type Introduction
- 2.1.1 On-premise
- 2.1.2 Cloud-based
- 2.1.3 Hybrid Mode
- 2.2 Global AI-based Diabetic Eye Disease Screening System Market Size by Type
- 2.2.1 Global AI-based Diabetic Eye Disease Screening System Market Size Overview by Type (2021-2032)
- 2.2.2 Global AI-based Diabetic Eye Disease Screening System Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global AI-based Diabetic Eye Disease Screening System Market Size Forecasted by Type (2027-2032)
- 2.3 Global AI-based Diabetic Eye Disease Screening System Market Size by Regions
- 2.3.1 North America AI-based Diabetic Eye Disease Screening System Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe AI-based Diabetic Eye Disease Screening System Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific AI-based Diabetic Eye Disease Screening System Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America AI-based Diabetic Eye Disease Screening System Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa AI-based Diabetic Eye Disease Screening System Market Size Breakdown by Type (2021-2026)
3 AI-based Diabetic Eye Disease Screening System Market by Application
- 3.1 Type Introduction
- 3.1.1 General Hospitals
- 3.1.2 Ophthalmology Hospitals
- 3.1.3 Diabetes Specialty Hospitals
- 3.2 Global AI-based Diabetic Eye Disease Screening System Market Size by Application
- 3.2.1 Global AI-based Diabetic Eye Disease Screening System Market Size Overview by Application (2021-2032)
- 3.2.2 Global AI-based Diabetic Eye Disease Screening System Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global AI-based Diabetic Eye Disease Screening System Market Size Forecasted by Application (2027-2032)
- 3.3 Global AI-based Diabetic Eye Disease Screening System Market Size by Regions
- 3.3.1 North America AI-based Diabetic Eye Disease Screening System Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe AI-based Diabetic Eye Disease Screening System Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific AI-based Diabetic Eye Disease Screening System Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America AI-based Diabetic Eye Disease Screening System Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa AI-based Diabetic Eye Disease Screening System Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 AI-based Diabetic Eye Disease Screening System Industry Trends
- 4.2 AI-based Diabetic Eye Disease Screening System Industry Drivers
- 4.3 AI-based Diabetic Eye Disease Screening System Industry Opportunities and Challenges
- 4.4 AI-based Diabetic Eye Disease Screening System Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by AI-based Diabetic Eye Disease Screening System Revenue (2021-2026)
- 5.2 Global AI-based Diabetic Eye Disease Screening System Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global AI-based Diabetic Eye Disease Screening System Key Company Headquarters & Area Served
- 5.4 Global AI-based Diabetic Eye Disease Screening System Company, Product Type & Application
- 5.5 Global AI-based Diabetic Eye Disease Screening System Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global AI-based Diabetic Eye Disease Screening System Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 AI-based Diabetic Eye Disease Screening System Players Market Share by Revenue in 2025
- 5.6.3 2025 AI-based Diabetic Eye Disease Screening System Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Remidio
- 6.1.1 Remidio Company Information
- 6.1.2 Remidio Business Overview
- 6.1.3 Remidio AI-based Diabetic Eye Disease Screening System Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Remidio AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.1.5 Remidio Recent Developments
- 6.2 Retmarker
- 6.2.1 Retmarker Company Information
- 6.2.2 Retmarker Business Overview
- 6.2.3 Retmarker AI-based Diabetic Eye Disease Screening System Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Retmarker AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.2.5 Retmarker Recent Developments
- 6.3 VoxelCloud
- 6.3.1 VoxelCloud Company Information
- 6.3.2 VoxelCloud Business Overview
- 6.3.3 VoxelCloud AI-based Diabetic Eye Disease Screening System Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 VoxelCloud AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.3.5 VoxelCloud Recent Developments
- 6.4 Airdoc
- 6.4.1 Airdoc Company Information
- 6.4.2 Airdoc Business Overview
- 6.4.3 Airdoc AI-based Diabetic Eye Disease Screening System Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Airdoc AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.4.5 Airdoc Recent Developments
- 6.5 Zhiyuan Huitu
- 6.5.1 Zhiyuan Huitu Company Information
- 6.5.2 Zhiyuan Huitu Business Overview
- 6.5.3 Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.5.5 Zhiyuan Huitu Recent Developments
- 6.6 IDx, LLC
- 6.6.1 IDx, LLC Company Information
- 6.6.2 IDx, LLC Business Overview
- 6.6.3 IDx, LLC AI-based Diabetic Eye Disease Screening System Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 IDx, LLC AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.6.5 IDx, LLC Recent Developments
- 6.7 Zhenhealth
- 6.7.1 Zhenhealth Company Information
- 6.7.2 Zhenhealth Business Overview
- 6.7.3 Zhenhealth AI-based Diabetic Eye Disease Screening System Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Zhenhealth AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.7.5 Zhenhealth Recent Developments
- 6.8 Eyenuk
- 6.8.1 Eyenuk Company Information
- 6.8.2 Eyenuk Business Overview
- 6.8.3 Eyenuk AI-based Diabetic Eye Disease Screening System Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Eyenuk AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.8.5 Eyenuk Recent Developments
- 6.9 AEYE Health
- 6.9.1 AEYE Health Company Information
- 6.9.2 AEYE Health Business Overview
- 6.9.3 AEYE Health AI-based Diabetic Eye Disease Screening System Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 AEYE Health AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.9.5 AEYE Health Recent Developments
- 6.10 Optomed
- 6.10.1 Optomed Company Information
- 6.10.2 Optomed Business Overview
- 6.10.3 Optomed AI-based Diabetic Eye Disease Screening System Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Optomed AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.10.5 Optomed Recent Developments
7 North America
- 7.1 North America AI-based Diabetic Eye Disease Screening System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026)
- 7.3 North America AI-based Diabetic Eye Disease Screening System Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe AI-based Diabetic Eye Disease Screening System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026)
- 8.3 Europe AI-based Diabetic Eye Disease Screening System Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific AI-based Diabetic Eye Disease Screening System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026)
- 9.3 Asia-Pacific AI-based Diabetic Eye Disease Screening System Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America AI-based Diabetic Eye Disease Screening System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026)
- 10.3 South America AI-based Diabetic Eye Disease Screening System Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026)
- 11.3 Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst